XML 58 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9
LONG-TERM DEBT AND OTHER BORROWINGS
6 Months Ended
Dec. 28, 2014
LONG-TERM DEBT AND OTHER BORROWINGS

NOTE 12 — LONG-TERM DEBT AND OTHER BORROWINGS

Convertible Senior Notes

In May 2011, the Company issued and sold $450.0 million in aggregate principal amount of 0.50% Convertible Senior Notes due May 2016 (the “2016 Notes”) at par. At the same time, the Company issued and sold $450.0 million in aggregate principal amount of 1.25% Convertible Senior Notes due May 2018 (the “2018 Notes”) at par. The Company pays cash interest at an annual rate of 0.5% and 1.25%, respectively, on the 2016 Notes and the 2018 Notes, on a semi-annual basis on May 15 and November 15 of each year.

In June 2012, with the acquisition of Novellus, the Company assumed $700.0 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 2041 (the “2041 Notes,” and collectively with the 2016 Notes and the 2018 Notes, the “Notes”). The Company pays cash interest at an annual rate of 2.625%, on a semi-annual basis on May 15 and November 15 of each year. The 2041 Notes also have a contingent interest payment provision that may require the Company to pay additional interest, up to 0.60% per year, based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes.

The Company separately accounts for the liability and equity components of the Notes. The initial debt components of the 2016 Notes, the 2018 Notes, and the 2041 Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature, which equals the effective interest rate on the liability component disclosed in the following table, respectively.

 

As of December 28, 2014 and June 29, 2014, the Notes consisted of the following:

 

     December 28, 2014     June 29, 2014  
     2016 Notes     2018 Notes     2041 Notes (1)     2016 Notes      2018 Notes      2041 Notes (1)  
     (in thousands, except years, percentages, conversion rate, and conversion price)  

Carrying value, long-term

   $ 427,443      $ 394,732      $ —        $ 419,561       $ 387,338       $ —     

Carrying value, current portion

     —          —          518,430        —           —           516,586   

Unamortized discount

     22,557        55,268        181,505        30,439         62,662         183,349   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Principal amount

$ 450,000    $ 450,000    $ 699,935    $ 450,000    $ 450,000    $ 699,935   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Remaining amortization period (years)

  1.4      3.4      26.4   

Effective interest rate on liability component

  4.29   5.27   4.28

Carrying amount of equity component, net of tax

$ 76,230    $ 104,895    $ 328,109   

Fair Value of Notes (Level 1)

$ 596,250    $ 645,188    $ 1,637,848   

Conversion rate (shares of common stock per $1,000 principal amount of notes)

  15.9868      15.9868      28.6901   

Conversion price (per share of common stock)

$ 62.55    $ 62.55    $ 34.86   

If-converted value in excess of par value

$ 132,431    $ 132,431    $ 925,839   

 

(1) During the quarter-ended December 28, 2014 and June 29, 2014 the market value of the Common Stock was greater than or equal to 130% of the 2041 Note conversion price for 20 or more trading days of the 30 consecutive trading days preceding the quarter end. As a result, the 2041 Notes are convertible at the option of the holder. The carrying amount of the 2041 Notes was classified in current liabilities and the excess of the amount of cash payable, if converted, over the carrying amount of the 2041 Notes was classified as temporary equity in the Company’s Consolidated Balance Sheets as of December 28, 2014 and June 29, 2014. Upon closure of a conversion period, all 2041 Notes not converted will be reclassified back to noncurrent liabilities and the temporary equity is reclassified to permanent equity.

The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the discount on the liability component of the Notes during the three and six months ended December 28, 2014 and December 29, 2013.

 

     Three Months Ended      Six Months Ended  
     December 28,
2014
     December 29,
2013
     December 28,
2014
     December 29,
2013
 
     (in thousands)  

Contractual interest coupon

   $ 6,562       $ 6,562       $ 13,124       $ 13,124   

Amortization of interest discount

     8,610         8,217         17,119         16,339   

Amortization of issuance costs

     590         591         1,181         1,181   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total interest cost recognized

$ 15,762    $ 15,370    $ 31,424    $ 30,644   
  

 

 

    

 

 

    

 

 

    

 

 

 

Convertible Note Hedges and Warrants

Concurrent with the issuance of the 2016 Notes and 2018 Notes, the Company sold warrants. At expiration, the Company may, at its option, elect to settle the warrants on a net share basis. As of December 28, 2014, the warrants had not been exercised and remained outstanding. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock.

 

In addition, counterparties agreed to sell to the Company shares of Common Stock equal to the number of shares issuable upon conversion of the 2016 Notes and 2018 Notes in full. The convertible note hedge transactions will be settled in net shares and will terminate upon the earlier of the maturity date or the first day none of the respective notes remain outstanding due to conversion or otherwise. Settlement of the convertible note hedge in net shares, based on the number of shares issued upon conversion of the Notes, on the expiration date would result in the Company receiving net shares equivalent to the number of shares issuable by the Company upon conversion of the 2016 Notes and 2018 Notes. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock. The following table presents the details of the warrants and convertible note hedge arrangements as of December 28, 2014:

 

     2016 Notes      2018 Notes  
     (shares in thousands)  

Warrants:

     

Number of shares to be delivered upon exercise

     7,194         7,194   

Exercise price

   $ 70.81       $ 75.54   

Expiration date range

    
 
August 15 -
October 21, 2016
  
  
    
 
August 15 -
October 23, 2018
  
  

Convertible Note Hedge:

     

Number of shares available from counterparties

     7,194         7,194   

Exercise price

   $ 62.55       $ 62.55   

Revolving Credit Facility

On March 12, 2014, the Company entered into a $300 million revolving unsecured credit facility with a syndicate of lenders. The facility matures on March 12, 2019. The facility includes an option, subject to certain requirements, for the Company to request an increase in the facility of up to an additional $200 million, for a potential total commitment of $500 million. Proceeds from the credit facility can be used for general corporate purposes.

Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (i) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) one-month LIBOR plus 1.0%, plus a spread of 0.0% to 0.5%, or (ii) LIBOR plus a spread of 0.9% to 1.5%, in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s rating described above. The credit facility contains certain restrictive covenants including maintaining a total consolidated indebtedness to consolidated capitalization ratio of no more than 0.5 to 1.0 and maintaining unrestricted or unencumbered cash and investments of no less than $1.0 billion. As of December 28, 2014, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.